CD8A and neoplasm: This increased frequency of tumour antigen-specific CD8+ TILs from Grail−/− mice was maintained at day 17 (Fig. 1c, d); however, we did not detect changes in the percentage of Grail−/− CD4+ TILs compared to WT (Fig. 1b, c).